Distraction Osteogenesis Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Distraction Osteogenesis Market Size, Share & Trends Analysis Report By Device Type, By Fixation Type, By Application, By Age Group, By End-user, By Region, And Segment Forecasts, 2024 – 2031

Distraction Osteogenesis Market Overview

The global distraction osteogenesis market reached US$ 238.03 million in 2023 and is expected to reach US$ 352.81 million by 2031, growing at a CAGR of 5.0% during the forecast period 2024-2031.

Distraction osteogenesis is a procedure which involves controlled elongation of the bone. It is majorly used in orthopedic and craniomaxillofacial surgeries to reconstruct or lengthen the bone. The usual process involves making a controlled fracture (osteotomy) in the bone and distracting the bone fragments using a device called a distractor allowing osteogenesis. Distraction osteogenesis is an alternative technique to bone grafting and tissue transfer, which does not require bone from other parts of the body. This is commonly employed in children with bone deformities, limb length problems, or craniofacial problems. 

Distraction Osteogenesis Market Scope

For more details on this report - Request for Sample

Distraction Osteogenesis Market Dynamics: Drivers

Rising technological advancements in distraction osteogenesis procedures

Distraction osteogenesis has become one of the crucial techniques in patients with bone, and craniomaxillofacial deformities, especially in pediatric patients. The procedure involves controlled osteotomy and bone growth promotion by using devices called distractors and fixators. These devices are mostly operated manually and may have several disadvantages such as creating inaccurate distraction, and minor vibrations while placement which is harmful to bone tissue healing. With the advent of technology, the current research is focused on developing automated devices called automated continuous distraction osteogenesis systems (ACDO) with improved accuracy.  

For instance, in March 2023, a study published in Elsevier evaluated the efficiency of an automated continuous distraction osteogenesis system for limb lengthening and reconstruction developed by scientists at the School of Mechanical Engineering, Beijing Institute of Technology, China, in collaboration with the Department of Orthopaedics, Beijing Jishuitan Hospital. The results indicated that the device is capable of producing continuous distraction osteogenesis with high precision and the device has the potential to induce very less pain as compared to manual devices, and also aid in tissue healing.

The adaptation of technology has been rising in surgery, in orthopedic and craniomaxillofacial surgery, especially 3D printing, virtual surgical planning (VSP), augmented reality, etc. These novel tools have been playing a crucial role in many surgical procedures and many explorative studies were being conducted to evaluate their clinical utility. 

For instance, on October 17, 2023, a study published in Innovative Surgical Sciences Journal utilized virtual surgical planning (VSP) software to correct hemifacial microsomia. The study utilized the CT scans of the patient to generate 3D virtual models, which enables the surgeon to practice and perform this complex correction procedure. 

In addition, on May 9, 2023, a clinical study published in Frontiers in Pediatrics which utilized the robotic navigation for distraction osteogenesis in hemifacial microsomia correction said that this advanced technology is safe and accurately translates the preoperative design intraoperatively and provides stable and reliable navigation support.

Also, increasing incidence of skeletal deformities, and rising demand for cosmetic procedures are expected to drive the market growth in the forecast period.

Restraints

The high cost of the treatment is one of the factors which may hinder the market growth. The complexity of the procedure may require special equipment according to the patient's needs and along with it the prolonged hospitalization and rehabilitation therapy may cost a lot to the patient. The affordability issue may arise in the low-middle-income countries which lack proper resources. Moreover, the limited availability of skilled personnel who can accurately perform the procedure is another factor that may restrain the market growth.

Distraction Osteogenesis Market Segment Analysis

The global distraction osteogenesis market is segmented based on device type, fixation type, application, age group, end user and region.

The oral and maxillofacial in the application segment accounted for approximately 70.4% of the global distraction osteogenesis market share

Distraction osteogenesis is a widely used technique for correcting craniomaxillofacial deformities that may arise due to congenital defects or accidents. The procedure is mainly used to correct mandible defects, maxilla, and mid-face bone deficiency. This surgical procedure is indicated in patients who are still growing, which means pediatric patients, in whom there is a higher scope of bone growth and regeneration. In adult patients, bone reconstitution remains the first-line option. In addition, the majority of the companies, which are the “established players” in the market offer a wide range of distractors and fixators suitable for craniomaxillofacial procedures.

For instance, KLS Martin Group, a major player in the market has a portfolio of distractors that are suited for only craniomaxillofacial osteogenesis. Likewise, Johnson and Johnson, Inc., offers a single product that is suited for maxillary osteogenesis. Similarly, several other established players like Stryker, Acumed LLC, and Surgi-Tec NV have the distractors used for craniomaxillofacial osteogenesis.

Distraction Osteogenesis Market Geographical Analysis 

North America is expected to dominate the market with a 52.15% share in the global distraction osteogenesis market

North America is expected to dominate the market due to its well-advanced healthcare infrastructure, and state-of-the-art hospitals equipped with high-end technologies. Moreover, the the major high-income countries in the region the U.S. and Canada are well-known for their investments in the healthcare industry. In addition, the research activities regarding distraction osteogenesis are higher in the region as compared to any other country in the world.

For instance, on November 2, 2022, a retrospective study published in the National Center for Biotechnology Information highlighted that the U.S. leads the world countries in distraction osteogenesis research. The reputed universities in the world, which are situated in the U.S. and Canada such as Harvard University, New York University, University of Michigan, and McGill University of Canada are the top universities conducting research activities concerning distraction osteogenesis. 

Moreover, the U.S. being the third most populous country in the world has the highest per-capita spending on healthcare. In addition, access to medical services is available for the majority of its population, along with favorable reimbursement policies for surgical procedures is one of the contributing factors to the region’s highest market share. 

For instance, as per Organization for Economic Co-operation and Development (OECD) statistics published in November 2023, The U.S. spends $12,555 per capita on health which is more than twice the OECD average, and 91% of the population has access to core health services in the country. 

COVID-19 Impact Analysis On Distraction Osteogenesis Market 

The COVID-19 pandemic has significantly impacted the global market for distraction osteogenesis which has led to decreased number of procedures. During the pandemic, all the healthcare resources were allocated to the care of virus-infected care, creating a delay in several surgical procedures, especially elective ones. Distraction osteogenesis procedures which are focused on correcting facial abnormalities for cosmetic purposes were thought to be halted during the pandemic period. This has created a deviation in the normal growth of the market.

For instance, on August 19, 2022, an article published in the National Center for Biotechnology Information stated that during the 12-week peak pandemic period in 2020, approximately 73% of the elective procedures were put on hold and more than 1 million joint and spinal surgeries backlogged in the U.S. till May 2022.

Distraction Osteogenesis Market Segmentation

By Device Type

• Distractors
  • Mandibular
  • Maxillary
  • Palatal
  • Limb & Extremities
  • Others
• Fixators
• Others

By Fixation Type

• External Fixation
• Internation Fixation

By Application

• Oral and Maxillofacial
• Limbs & Extremities

By Age Group

• Pediatrics
• Adults

By End User

• Hospitals
• Orthopedic Specialty Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Distraction Osteogenesis Market Competitive Landscape

The major players in the distraction osteogenesis market include KLS Martin Group., Acumed LLC, Johnson & Johnson Services, Inc., TITAMED, Stryker, Surgi-Tec nv, Narang Medical Limited., Orthofix Medical Inc., NuVasive, Inc. and Zimmer Biomet. among others. 

Why Purchase the Report?

• To visualize the global distraction osteogenesis market segmentation based on device type, fixation type, application, age group, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of distraction osteogenesis market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global distraction osteogenesis market report would provide approximately 78 tables, 69 figures, and 187 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies